Maria Teresa Fulciniti (Mariateresa Fulciniti)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Multiple Myeloma

Gene Expression

Top Venues

Blood cancer journal

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Moritz Binder, Raphael E Szalat, Srikanth Talluri, Maria Teresa Fulciniti, Hervé Avet-Loiseau, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes. Nature communications 15 (1) (2024)
Moritz Binder, Raphael E Szalat, Srikanth Talluri, Maria Teresa Fulciniti, Hervé Avet-Loiseau, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes. Nature communications 15 (1) (2024)
Judith Lind, Osman Aksoy, Michaela Prchal-Murphy, Fengjuan Fan, Maria Teresa Fulciniti, Dagmar Stoiber, Latifa Bakiri, Erwin F Wagner, Elisabeth Zwickl-Traxler, Martin Sattler, Karoline Kollmann, Sonia Vallet, Klaus Podar
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity. Blood cancer journal 14 (1) (2024)
Judith Lind, Osman Aksoy, Michaela Prchal-Murphy, Fengjuan Fan, Maria Teresa Fulciniti, Dagmar Stoiber, Latifa Bakiri, Erwin F Wagner, Elisabeth Zwickl-Traxler, Martin Sattler, Karoline Kollmann, Sonia Vallet, Klaus Podar
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity. Blood cancer journal 14 (1) (2024)
Judith Lind, Osman Aksoy, Michaela Prchal-Murphy, Fengjuan Fan, Maria Teresa Fulciniti, Dagmar Stoiber, Latifa Bakiri, Erwin F Wagner, Elisabeth Zwickl-Traxler, Martin Sattler, Karoline Kollmann, Sonia Vallet, Klaus Podar
Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity. Blood cancer journal 14 (1) (2024)
Moritz Binder, Raphael E Szalat, Srikanth Talluri, Maria Teresa Fulciniti, Hervé Avet-Loiseau, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes. Nature communications 15 (1) (2024)
Moritz Binder, Raphael E Szalat, Srikanth Talluri, Maria Teresa Fulciniti, Hervé Avet-Loiseau, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
Bone marrow stromal cells induce chromatin remodeling in multiple myeloma cells leading to transcriptional changes. Nature communications 15 (1) (2024)
Debasmita Dutta, Jiye Liu, Kenneth Wen, Keiji Kurata, Maria Teresa Fulciniti, Annamaria Gulla, Teru Hideshima, Kenneth C Anderson
BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma. Blood cancer journal 13 (1) (2023)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Anil Aktas Samur, Maria Teresa Fulciniti, Herve Avet-Loiseau, Michael A Lopez, Sanika Derebail, Jill Corre, Stephane Minvielle, Florence Magrangeas, Philippe Moreau, Kenneth C Anderson, Giovanni Parmigiani, Mehmet Kemal Samur, Nikhil C Munshi
In-depth analysis of alternative splicing landscape in multiple myeloma and potential role of dysregulated splicing factors. Blood cancer journal 12 (12) (2022)
Mehmet Kemal Samur, Maria Teresa Fulciniti, Anil Aktas Samur, Abdul-Hamid Bazarbachi, Yu-Tzu Tai, Rao Prabhala, Alejandro Alonso, Adam S Sperling, Timothy Campbell, Fabio Petrocca, Kristen Hege, Shari Kaiser, Hervé Avet Loiseau, Kenneth C Anderson, Nikhil C Munshi
Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma. Nature communications 12 (1) (2021)
Shayna R Sarosiek, Cindy Varga, Allison Jacob, Maria Teresa Fulciniti, Nikhil C Munshi, Vaishali Sanchorawala
Detection of minimal residual disease by next generation sequencing in AL amyloidosis. Blood cancer journal 11 (6) (2021)